background
limit
culturebas
molecular
method
screen
staphylococc
infect
current
test
determin
presenc
absenc
colon
inform
colon
strain
type
techniqu
coupl
polymeras
chain
reaction
mass
spectrometri
pcresim
recent
develop
assay
valid
identifi
genotyp
aureu
coagulaseneg
staphylococci
con
method
studi
conduct
determin
rate
risk
factor
molecular
genotyp
colon
staphylococcu
aureu
adult
patient
present
innerc
academ
emerg
depart
particip
complet
structur
questionnair
assess
hospit
commun
risk
infect
methicillinresist
aureu
mrsa
nasal
swab
analyz
pcresim
identifi
genotyp
aureu
con
result
patient
evalu
colon
aureu
methicillinresist
strain
twentyfour
aureu
carrier
cocolon
con
patient
colon
exclus
con
molecular
genotyp
aureu
strain
divers
uniqu
molecular
genotyp
belong
seven
major
clonal
complex
identifi
eightyf
patient
carri
strain
highlevel
mupirocin
resist
eightyf
particip
colon
exclus
aureu
cocolon
aureu
con
colon
exclus
con
conclus
preval
aureu
methicillinresist
aureu
colon
random
sampl
patient
seek
care
emerg
depart
respect
substanti
fraction
aureuscolon
patient
cocolon
con
highlevel
mupirocinresist
con
determin
molecular
genotyp
aureu
intak
screen
may
prove
valuabl
futur
certain
molecular
genotyp
becom
associ
increas
infect
risk
staphylococcu
aureu
major
caus
healthcareassoci
infect
although
sever
epidemiolog
studi
provid
inform
preval
methicillinresist
staphylococcu
aureu
mrsa
colon
differ
hospit
set
emerg
depart
personnel
limit
data
exist
mrsa
colon
rate
patient
seen
emerg
depart
cost
benefit
screen
mrsa
colon
overwhelm
subject
controversi
limit
culturebas
molecular
method
mrsa
screen
current
test
determin
presenc
absenc
colon
inform
colon
strain
type
small
subset
mrsa
clone
respons
major
epidem
unit
state
screen
might
greater
valu
futur
studi
demonstr
certain
clone
like
caus
seriou
infect
other
develop
rapid
molecular
surveil
assay
base
pcr
coupl
electrospray
ioniz
mass
spectrometri
pcresim
identifi
provid
detail
inform
aureu
strain
previou
version
assay
shown
accur
genotyp
aureu
strain
identifi
clonal
complex
seri
isol
center
diseas
control
cdc
excel
agreement
multilocu
sequenc
type
mlst
pulsedfield
gel
electrophoresi
pfge
result
reach
use
pcresim
assay
set
eight
primer
pair
target
gene
mlst
set
primer
pair
design
optim
inform
content
amplicon
distinguish
distinct
aureu
sequenc
type
use
second
set
eight
primer
pair
pcresim
also
use
character
virul
factor
toxinencod
gene
antibiot
resist
determin
isol
coloni
detect
mrsa
nasal
swab
sensit
specif
similar
cultur
method
work
element
previou
studi
consolid
singl
pcresim
research
applic
directli
screen
nasal
swab
sampl
patient
present
urban
hospit
emerg
depart
prospect
surveil
studi
conveni
sampl
adult
patient
conduct
john
hopkin
emerg
depart
maryland
august
februari
john
hopkin
hospit
emerg
depart
see
approxim
patient
month
urgent
care
center
ucc
bed
dedic
shortstay
emerg
acut
care
unit
eacu
bed
also
part
emerg
depart
servic
patient
includ
studi
patient
visit
adult
emerg
depart
evalu
potenti
treatment
elig
studi
except
prison
patient
unabl
understand
studi
requir
enrol
patient
sampl
conveni
hour
studi
coordin
avail
includ
patient
seen
mondayfriday
hour
pm
exclud
patient
previous
known
risk
factor
mrsa
colon
patient
fever
greater
abscess
cellul
infect
wound
known
previou
mrsa
infect
histori
inject
drug
use
three
hundr
patient
approach
particip
twothird
met
studi
criteria
ultim
consent
particip
studi
particip
provid
verbal
inform
consent
studi
approv
john
hopkin
institut
review
board
anterior
nasal
specimen
obtain
use
bbl
cultur
swab
plu
doubl
applic
becton
dickinson
spark
md
patient
swab
insert
left
right
nostril
studi
subject
one
studi
coordin
collect
specimen
swab
inocul
mannitol
salt
broth
allow
sit
minut
room
temperatur
swab
express
broth
incub
hour
incub
sampl
ad
tube
contain
zirconia
bead
lysi
buffer
sampl
subject
bead
beat
minut
biospec
mini
bead
beater
bartlesvil
ok
supernat
transfer
king
fisher
processor
nucleic
acid
isol
use
ambion
total
nucleic
acid
tna
kit
ambion
austin
tx
nucleic
acid
analyz
eight
pcr
reaction
contain
duplex
pcr
primer
pair
tabl
pcr
esim
platform
avail
research
applic
ibi
bioscienc
abbott
carlsbad
ca
determin
methicillinresist
statu
specimen
patient
cocolon
aureu
con
sampl
streak
chromagar
becton
dickinson
bioscienc
san
jose
ca
plate
incub
hour
studi
combin
element
previou
genotyp
character
assay
singl
format
ad
primer
pair
interrog
gene
toxic
shock
syndrom
toxin
pvl
gene
distinguish
r
h
variant
region
ile
gene
encod
low
level
mupirocin
resist
thu
current
assay
figur
use
eight
amplificationmass
spectrometri
measur
simultan
detect
gene
fragment
use
staphylococcu
genotyp
unambigu
identifi
aureu
lugdunensi
distinguish
speci
well
coagulaseneg
staphylococc
speci
addit
aureu
detect
presenc
absenc
pvl
distinct
r
h
variant
meca
gene
gene
encod
gene
encod
high
level
mupa
low
level
ile
mupirocin
resist
determin
along
clonal
complex
turnaround
time
assay
studi
includ
time
analysi
hour
first
sampl
sampl
analyz
hour
period
structur
nineitem
questionnair
design
base
review
relev
literatur
identifi
patient
demograph
characterist
hospit
andor
commun
mrsa
acquisit
inform
collect
includ
patient
demograph
age
sex
race
reason
visit
ed
whether
histori
prescrib
antibiot
histori
admiss
hospit
patient
medic
record
review
provid
clarif
preval
estim
calcul
estim
proport
emerg
depart
patient
mrsa
colon
identif
clinic
featur
associ
mrsa
colon
initi
assess
use
bivari
analysi
variabl
collect
patient
data
sheet
relat
mrsa
colon
enter
bivari
logist
regress
model
gener
odd
ratio
correspond
confid
interv
factor
control
potenti
confound
total
individu
recruit
met
elig
criteria
studi
demograph
inform
studi
particip
present
tabl
result
pcresim
analysi
nasal
swab
particip
illustr
figur
primer
set
use
analyz
nasal
swab
contain
primer
pair
target
highli
conserv
tufb
gene
amplifi
speci
within
staphylococcu
genu
bacteri
genera
differ
mass
amplicon
mass
spectra
distinguish
aureu
lugdunensi
speci
staphylococci
identifi
aureu
con
present
patient
sampl
spectral
peak
speci
observ
spectrum
similarli
primer
pair
target
gmk
gene
part
genotyp
compon
assay
also
amplifi
distinguish
aureu
con
patient
present
emerg
depart
colon
aureu
patient
also
cocolon
con
figur
one
hundr
forti
colon
exclus
con
one
patient
show
evid
staphylococc
colon
distribut
meca
gene
methicillin
resist
gene
mupa
gene
respons
high
level
mupirocin
resist
among
detect
staphylococcu
speci
also
report
figur
patient
colon
aureu
methicillinsensit
aureu
mssa
mrsa
mssa
patient
colon
strain
carri
gene
highlevel
mupirocin
resist
mrsa
isol
mupirocin
resist
gene
con
posit
patient
colon
strain
mupirocin
resist
gene
methicillin
resist
gene
gene
encod
methicillin
mupirocin
resist
among
patient
cocolon
coloni
methicillin
highlevel
mupirocin
resist
methicillin
resist
cocolon
locat
antibiot
resist
gene
could
determin
directli
pcresim
amplicon
produc
irrespect
bacteri
strain
instead
speci
carri
gene
determin
plate
sampl
chromagar
order
demonstr
one
coloni
type
sinc
ten
instanc
methicillin
resist
could
thu
attribut
aureu
patient
colon
aureu
inde
colon
mrsa
also
patient
altogeth
colon
strain
carri
gene
encod
highlevel
mupirocin
resist
genotyp
presenc
virul
factor
uniqu
aureu
determin
patient
figur
flow
scheme
pcresim
genotyp
character
aureu
dna
nasal
swab
distribut
eight
well
microtit
plate
allow
sampl
analyz
per
plate
well
contain
two
pair
primer
indic
tabl
follow
pcr
desalt
amplicon
analyz
esim
amplicon
mass
use
calcul
base
compositionsth
g
c
count
pcr
product
comparison
databas
calcul
base
composit
character
strain
allow
determin
clonal
complex
usa
type
presenc
absenc
gene
virul
factor
toxin
antibiot
resist
determin
colon
aureu
regardless
whether
patient
cocolon
con
genotyp
character
result
shown
tabl
aureu
isol
show
remark
divers
isol
cluster
genotyp
depict
uniqu
row
tabl
one
genotyp
detect
instanc
tabl
patient
popul
patient
uniqu
genotyp
examin
perspect
clonal
complex
uniqu
molecular
genotyp
belong
seven
major
clonal
complex
cc
tabl
abund
genotyp
pcresim
type
patient
correl
follow
pcresim
type
correl
patient
eleven
patient
genotyp
pcresim
type
posit
pvl
r
variant
genotyp
consist
predomin
communityassoci
mrsa
camrsa
us
pcresim
type
isol
patient
isol
pvl
neg
organ
consist
hospitalacquir
mrsa
hamrsa
pcresim
type
repres
slightli
half
organ
isol
patient
popul
remaind
repres
plural
cc
genotyp
fit
previous
defin
clonal
complex
tabl
addit
molecular
resolut
beyond
pcresim
type
provid
presenc
absenc
lukd
gene
gene
encod
toxin
region
two
leukocidin
toxinproduc
operon
amplifi
singl
pair
primer
region
pantonvalentin
leukocidin
pvl
operon
includ
lukspv
lukfpv
gene
target
primer
pair
hybrid
across
junction
end
lukspv
end
lukfpv
primer
pair
serendipit
detect
differenti
virtu
base
composit
second
leukotoxinencod
operon
contain
luke
lukd
gene
thu
analysi
isol
four
potenti
outcom
pvl
posit
luke
posit
posit
neither
posit
lukd
gene
gener
correl
clonal
complex
assign
recent
shown
gene
encod
protein
associ
pfge
type
isol
studi
tst
gene
present
two
four
instanc
genotyp
studi
mutat
associ
lowlevel
mupirocin
resist
observ
ile
gene
within
data
set
patient
demograph
primari
complaint
antibiot
prescript
provid
admiss
decis
evalu
associ
particular
pathogen
independ
factor
associ
type
colon
howev
african
american
like
colon
usa
aureu
genotyp
race
versu
p
emerg
depart
high
preval
mrsa
isol
patient
sporad
skin
softtissu
infect
limit
research
explor
nasal
mrsa
carriag
popul
mechan
lead
aureu
nasal
carriag
multifactori
optim
fit
host
bacteria
seem
essenti
studi
demonstr
signific
preval
aureu
mrsa
drugresist
con
nasal
colon
random
sampl
individu
seek
care
emerg
depart
john
hopkin
hospit
preval
mrsa
among
nasal
isol
somewhat
greater
estim
studi
similar
object
sampl
popul
three
studi
perform
outsid
healthcar
facil
ie
isol
semiclos
rural
popul
urban
poor
san
francisco
univers
student
portug
includ
total
peopl
show
pool
mrsa
colon
preval
preval
mrsa
colon
inpati
set
tertiari
hospit
report
find
similar
preval
note
studi
investig
preval
mrsa
among
newli
arrest
men
baltimor
studi
vs
aureu
mrsa
preval
respect
studi
identifi
three
risk
factor
mrsa
colon
hospit
within
past
month
previou
mrsa
infect
inject
drug
use
risk
factor
alreadi
identifi
exclus
criteria
studi
although
evalu
patient
demograph
primari
complaint
chronic
comorbid
antibiot
prescript
provid
admiss
decis
none
independ
risk
factor
mrsa
colon
data
confirm
recent
epidemiolog
data
indic
nosocomi
mrsa
strain
present
commun
interestingli
substanti
genotyp
divers
aureu
mrsa
type
patient
popul
signific
frequenc
cocolon
aureu
con
patient
least
one
third
patient
colon
con
highlevel
mupirocin
resist
gene
patient
noncount
aureu
coinfect
concern
previous
report
gene
highlevel
mupirocin
resist
found
conjug
plasmid
carri
multipl
resist
determin
antimicrobi
agent
moreov
resist
shown
transfer
aureu
implic
mupirocin
decolon
strategi
pcresim
methodolog
oper
autom
highthroughput
platform
patient
specimen
screen
without
cultur
result
obtain
time
frame
similar
exist
molecular
test
data
extens
analysi
aureu
strain
result
hospit
infect
becom
avail
addit
target
genet
analysi
aureu
ad
goal
assay
add
target
provid
inform
valu
infect
control
track
outbreak
hospit
set
limit
current
assay
lack
resolut
compar
technolog
acknowledg
inclus
type
tsst
pvl
would
probabl
aid
clinic
scenario
might
aid
research
studi
predictor
subsequ
infect
hospit
patient
studi
studi
perform
one
locat
john
hopkin
hospit
emerg
depart
therefor
result
may
applic
area
unit
state
although
ethnic
divers
studi
particip
similar
popul
john
hopkin
hospit
patient
african
american
result
may
applic
ethnic
divers
area
unit
state
also
note
literatur
cite
signific
heterogen
risk
factor
nasal
aureu
mrsa
colon
well
fact
survey
nasal
conclus
preval
aureu
mrsa
colon
conveni
sampl
patient
seek
care
emerg
depart
respect
substanti
fraction
aureuscolon
patient
cocolon
con
highlevel
mupirocinresist
con
find
highlight
import
activ
surveil
studi
detect
mrsa
colon
andor
infect
among
emerg
depart
patient
molecular
genotyp
directli
identifi
nasal
swab
pcresim
abil
identifi
uniqu
molecular
signatur
mrsa
may
allow
infect
control
resourc
effect
focus
enabl
track
origin
outbreak
hospit
set
determin
molecular
genotyp
aureu
intak
screen
may
prove
valuabl
certain
molecular
genotyp
becom
associ
increas
infect
risk
author
contribut
ak
cg
rr
dje
rs
lbb
conceiv
studi
particip
design
coordin
help
draft
manuscript
rr
cm
carri
genotyp
character
assay
draft
manuscript
yhh
particip
design
studi
perform
statist
analysi
author
read
approv
final
manuscript
